The Effect of Citalopram Pretreatment on Neuronal Responses to Neuropsychological Tasks in Normal Volunteers: An fMRI Study
The DOI matches its Crossref record; 86 of the 88 references it cites were found in a registry or an index.
Abstract
Changes in serotonin neurotransmission have also been implicated in the etiology and treatment of impulse control disorders, depression, and anxiety. We have investigated the effect of enhancing serotonin function on fundamental brain processes that we have proposed are abnormal in these disorders. In all, 12 male volunteers received citalopram (7.5 mg intravenously) and placebo pretreatment in a single-blind crossover design before undertaking Go/No-go, Loss/No-loss, and covert (aversive) face emotion recognition tasks during functional magnetic resonance imaging (fMRI). Blood oxygenation level dependent responses were analyzed using Statistical Parametric Mapping (SPM2). The tasks activated prefrontal and subcortical regions generally consistent with literature with lateral orbitofrontal cortex (BA47) common to the three tasks. Citalopram pretreatment enhanced the right BA47 responses to the No-go condition, but attenuated this response to aversive faces. Attenuations were seen following citalopram in the medial orbitofrontal (BA11) responses to the No-go and No-loss (ie relative reward compared with Loss) conditions. The right amygdala response to aversive faces was attenuated by citalopram. These results support the involvement of serotonin in modulating basic processes involved in psychiatric disorders but argue for a process-specific, rather than general effect. The technique of combining drug challenge with fMRI (pharmacoMRI) has promise for investigating human psychiatric disorders.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“ADs were shown to have an early effect on the neural networks dysfunctional in depression and proposed as the neural ‘scaffolding’ for the negative bias formation”
From Cognitive neuropsychological theory of antidepressant action: a modern-day approach to depression and its treatment (2021) · cites this paper as Del-Ben et al. 2005
In the citing paper
“changes in response to emotionally salient information were also observed across other relevant structures, such as medial prefrontal cortex (mPFC), insula, ventral striatum, thalamus, orbito-frontal cortex and dlPFC”
From Cognitive neuropsychological theory of antidepressant action: a modern-day approach to depression and its treatment (2021) · cites this paper as Del-Ben et al. 2005
In the citing paper
“Most consistent and robust reports regarded the amygdala and the ACC”
From Cognitive neuropsychological theory of antidepressant action: a modern-day approach to depression and its treatment (2021) · cites this paper as Del-Ben et al. 2005
In the citing paper
“Consistent effects have not been found in other brain regions although in 2 studies viewing negative emotions had opposite effects on right VLPFC of lowering 5-HT function with ATD and increasing it with citalopram (leading to increased and decreased activation respectively) (Del-Ben et al., 2005;Fusar-Poli et al., 2007).”
From Affective Cognition and its Disruption in Mood Disorders (2011) · cites this paper as Del-Ben et al., 2005
In the citing paper
“Studies acutely enhancing 5-HT function with citalopram have found decreased amygdala responses to negative compared with neutral faces (Anderson et al., 2007;Del-Ben et al., 2005;Murphy et al., 2009a) but increased activation comparing faces (emotional and neutral) and a sensorimotor control task (Bigos et al., 2008).”
From Affective Cognition and its Disruption in Mood Disorders (2011) · cites this paper as Del-Ben et al., 2005
2 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
(1998) · The Journal of Clinical Psychiatry · Cited by 19,139
Co-Planar Stereotaxic Atlas of the Human Brain
Talairach, J., & Tournoux, P. (1988) · Medical Entomology and Zoology · Cited by 11,798
The expression of the emotions in man and animals.
Darwin, C. (1872) · J. Murray eBooks · doi:10.1037/10001-000 · Cited by 11,657
Insensitivity to future consequences following damage to human prefrontal cortex
Bechara, A., Damasio, A. R., Damasio, H., & Anderson, S. W. (1994) · Cognition · doi:10.1016/0010-0277(94)90018-3 · Cited by 6,128 · cited 1×
“…in recognition and processing of reward and punishment stimuli, with some findings suggesting an anatomical division of its functions with lateral areas associated with loss/punishment and medial areas more with reward (Bechara et al, 1994; O'Doherty et al, 2001; Elliott et al, 2003).”
BackgroundEkman, P. (1976) · Medical Entomology and Zoology · Cited by 4,345
Functional neuroanatomy of emotion: A meta-analysis of emotion activation studies in PET and fMRI
Phan, K. L., Wager, T., Taylor, S. F., & Liberzon, I. (2002) · NeuroImage · doi:10.1006/nimg.2002.1087 · Cited by 3,502 · cited 1×
“…to visualize the functional neuroanatomy of specific components of emotional processing such as response to reward and punishment (Elliott et al, 2000b), fear conditioning (Morris et al, 2001), emotion recognition (for a review, see Phan et al, 2002), and impulse control (Casey et al, 1997).”
BackgroundA differential neural response in the human amygdala to fearful and happy facial expressions
Morris, J. S., Frith, C. D., Perrett, D. I., Rowland, D., Young, A. W., Calder, A. J., & Dolan, R. J. (1996) · Nature · doi:10.1038/383812a0 · Cited by 2,013 · cited 3×
“…relating to fearful faces (eg Morris et al, 1996; Hariri et al, 2000; Phillips et al, 2001), a response that is lateralized in some studies (eg Morris et al, 1996), possibly relating to different rates of habituation with one study finding faster habituation in the right than left amygdala to…”
BackgroundMethodAbstract reward and punishment representations in the human orbitofrontal cortex
O'Doherty, J., Kringelbach, M. L., Rolls, E. T., Hornak, J., & Andrews, C. (2001) · Nature Neuroscience · doi:10.1038/82959 · Cited by 2,003
KRINGELBACH, M. (2004) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2004.03.006 · Cited by 1,977 · cited 2×
“Other studies have also reported medial OFC responses to rewarding stimuli (see Kringelbach and Rolls, 2004, for a review).”
BackgroundStop-signal inhibition disrupted by damage to right inferior frontal gyrus in humans
Aron, A. R., Fletcher, P. C., Bullmore, E. T., Sahakian, B. J., & Robbins, T. W. (2003) · Nature Neuroscience · doi:10.1038/nn1003 · Cited by 1,771 · cited 2×
“The lateral orbitofrontal cortex (OFC), particularly on the right, is a common area activated by No-go compared with Go conditions in these studies and appears to be specifically involved in the inhibition of responses (Aron et al, 2003; Rubia et al, 2003; Menon et al, 2001; Liddle et al, 2001).”
Background
Research works printed but not linked: 3
- First MB, Spitzer RL, Gibbon M, Williams JBW (2002). Structured Clinical Interview for DSM-IV-TR Axis I Disorders, Research Version, Non-patient Edition. Biometrics Research, New York State Psychiatric Institute: (SCID-I/NP) New York.
- Longe O, Deakin JFW, Elliott R (2003). Anticipating reinforcement in Unipolar Depression Presented at the ninth International Conference on Functional Mapping of the Human Brain, June 19–22, 2003, New York, NY. Available on CD-Rom in NeuroImage 19 (Volume 2).
- Talairach J, Tournoux P (1988). Coplanar Stereotactic Atlas of the Human Brain. George Thieme Verlag: Stuttgart.
Cited by
Items 101–200 of 260
Ravinder, S., Burghardt, N. S., Brodsky, R., Bauer, E. P., & Chattarji, S. (2013) · Translational Psychiatry · doi:10.1038/tp.2012.137 · Cited by 59
Selvaraj, S., Walker, C., Arnone, D., Cao, B., Faulkner, P., Cowen, P. J., Roiser, J. P., & Howes, O. (2018) · Neuropsychopharmacology · doi:10.1038/npp.2017.166 · Cited by 58
“Second, although N= 13 is comparable to the size of similar studies (Bigos et al, 2008; Del-Ben et al, 2005), the sample size for the combined PET/fMRI experiment does not permit investigation of additional potential moderators (eg, 5-HTT genetic polymorphisms) on the influence of the 5-HT1A…”
BackgroundMethodResultInfluentialReversed Frontotemporal Connectivity During Emotional Face Processing in Remitted Depression
Goulden, N., McKie, S., Thomas, E. J., Downey, D., Juhasz, G., Williams, S. R., Rowe, J. B., Deakin, J. F. W., Anderson, I. M., & Elliott, R. (2012) · Biological Psychiatry · doi:10.1016/j.biopsych.2012.04.031 · Cited by 58
Self-citationPregabalin Influences Insula and Amygdala Activation During Anticipation of Emotional Images
Aupperle, R. L., Ravindran, L. N., Tankersley, D., Flagan, T., Stein, N. R., Simmons, A. N., Stein, M. B., & Paulus, M. P. (2011) · Neuropsychopharmacology · doi:10.1038/npp.2011.32 · Cited by 63
“Although dose influenced both subjective ratings and CPT performance, the subjective measures (KSS, STAI, VAS ratings) were not significantly correlated with valence aspects of CPT performance (accuracy, reaction time).”
BackgroundResultBellani, M., Dusi, N., Yeh, P., Soares, J. C., & Brambilla, P. (2010) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2010.11.040 · Cited by 60
“In healthy subjects, SSRIs, such as citalopram, escitalopram, and fluvoxamine have been reported to reduce amygdalar, OFC, hippocampal, parahippocampal and insular activation compared to placebo during aversive stimuli in most (but not all) of the fMRI studies (Del-Ben et al., 2005; Takahashi et al., 2005; Harmer et a…”
ResultSerotonergic modulation of reward and punishment: evidence from pharmacological fMRI studies
Macoveanu, J. (2014) · Brain Research · doi:10.1016/j.brainres.2014.02.003 · Cited by 55
Laursen, H. R., Siebner, H. R., Haren, T., Madsen, K., Grønlund, R., Hulme, O., & Henningsson, S. (2014) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2014.00423 · Cited by 56
“These 50 participants were scanned between day 5 and 12 of the menstrual cycle, with the exception of four subjects who reported irregular periods.”
BackgroundInfluentialRisk assessment and serotonin: Animal models and human psychopathologies
Blanchard, D. C., & Meyza, K. Z. (2017) · Behavioural Brain Research · doi:10.1016/j.bbr.2017.07.008 · Cited by 55
The motor system and its disorders
Rowe, J. B., & Siebner, H. R. (2011) · NeuroImage · doi:10.1016/j.neuroimage.2011.12.042 · Cited by 64
“…activation of lateral prefrontal, premotor and parietal cortex with successful inhibition in NoGo trials (Asahi et al., 2004; Chikazoe et al., 2007, 2009a; Del-Ben et al., 2005; Konishi et al., 1998, 1999; Langenecker et al., 2007; Rubia et al., 2005; Simmonds et al., 2008; Zheng et al., 2008).”
BackgroundResultInfluentialAntidepressant-related sexual dysfunction — Perspectives from neuroimaging
Graf, H., Walter, M., Metzger, C. D., & Abler, B. (2013) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2013.12.003 · Cited by 56
Interaction between a history of depression and rumination on neural response to emotional faces
Thomas, E. J., Elliott, R., McKie, S., Arnone, D., Downey, D., Juhasz, G., Deakin, J. F. W., & Anderson, I. M. (2011) · Psychological Medicine · doi:10.1017/s0033291711000043 · Cited by 53
“…face emotion processing have been suggested to represent an important neurobiological marker for depression (Fu et al. 2004, 2007 ; Harmer et al. 2009) and antidepressant administration has been shown to modulate neural response to emotional faces (e.g. Del-Ben et al. 2005; Anderson et al. 2007).”
BackgroundSelf-citationRose, E. J., Simonotto, E., Spencer, E. P., & Ebmeier, K. P. (2006) · Psychopharmacology · doi:10.1007/s00213-006-0334-2 · Cited by 62
Macoveanu, J., Hornboll, B., Elliott, R., Erritzoe, D., Paulson, O. B., Siebner, H., Knudsen, G. M., & Rowe, J. B. (2013) · Neuropsychopharmacology · doi:10.1038/npp.2012.264 · Cited by 47
“Such an interaction would explain some of the behavioral and imaging differences between healthy individuals (Del-Ben et al, 2005; Rubia et al, 2005; Evers et al, 2006; Lamar et al, 2009) and patients (LeMarquand et al, 1998; Zepf et al, 2008).”
BackgroundMethodResultSelf-citationSerotonergic regulation of the dopaminergic system: Implications for reward-related functions
Courtiol, E., Menezes, E. D. C., & Teixeira, C. M. (2021) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2021.06.022 · Cited by 53
Grady, C. L., Siebner, H. R., Hornbøll, B., Macoveanu, J., Paulson, O. B., & Knudsen, G. M. (2012) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2012.06.003 · Cited by 50
Lanius, R. A., Brewin, C. R., Bremner, J. D., Daniels, J. K., Friedman, M. J., Liberzon, I., McFarlane, A., Schnurr, P. P., Shin, L., Stein, M., et al. (2010) · Journal of Psychiatry and Neuroscience · doi:10.1139/jpn.090047 · Cited by 46
“In contrast, citalopram attenuated right BA 47 responses but attenuated right amygdala response to aversive faces.(29)”
The Role of the Amygdala in Anxiety Disorders
L., G., M., A., L., J., & J., M. (2012) · The Amygdala - A Discrete Multitasking Manager · doi:10.5772/50323 · Cited by 45
“However, acute doses of citalopram have also been found to decrease amygdala activation to fearful faces [208,210,211].”
BackgroundVriend, C. (2018) · Cell and Tissue Research · doi:10.1007/s00441-017-2771-0 · Cited by 52
“In healthy humans, the SSRI citalopram enhanced activity of inhibition-related brain areas during a Go/No-Go task but had no effect on behavioral performance (Del-Ben et al. 2005; Macoveanu et al. 2012).”
Pregabalin effects on neural response to emotional faces
Aupperle, R. L., Tankersley, D., Ravindran, L. N., Flagan, T., Stein, N. R., Stein, M. B., & Paulus, M. P. (2012) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2012.00042 · Cited by 46
Acute Effects of the Novel Psychoactive Drug 2C-B on Emotions
González, D., Torrens, M., & Farré, M. (2015) · BioMed Research International · doi:10.1155/2015/643878 · Cited by 43
The Role of Serotonin in Orbitofrontal Function and Obsessive-Compulsive Disorder
Maia, T. V., & Cano-Colino, M. (2015) · Clinical Psychological Science · doi:10.1177/2167702614566809 · Cited by 42
“Conversely, several neuroimaging studies have shown that serotonergic manipulations affect OFC activation during response inhibition in go/no-go tasks (Anderson, McKie, Elliott, Williams, & Deakin, 2008; Del-Ben et al., 2005; Rubia et al., 2005; Völlm et al., 2006).”
BackgroundKerestes, R., Labuschagne, I., Croft, R. J., O’Neill, B. V., Bhagwagar, Z., Phan, K. L., & Nathan, P. J. (2008) · Psychopharmacology · doi:10.1007/s00213-008-1340-3 · Cited by 48
Schmidt, A., Müller, F., Dolder, P. C., Schmid, Y., Zanchi, D., Liechti, M. E., & Borgwardt, S. (2017) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyx037 · Cited by 41
“Along this line, citalopram also increased activation in the right dorsolateral prefrontal cortex and middle frontal gyrus in healthy subjects during the go/no-go task (Del-Ben et al., 2005).”
The role of neuroimaging for the diagnosis and treatment of anxiety disorders
Paulus, M. P. (2008) · Depression and Anxiety · doi:10.1002/da.20499 · Cited by 39
Why Symbolic Processing of Affect Can Disrupt Negative Affect
Lieberman, M. D. (2011) · Social Neuroscience · doi:10.1093/acprof:oso/9780195316872.003.0013 · Cited by 38
“Finally, pharmacological studies in which participants receive serotonergic agonists, associated with enhanced self-control and diminished impulsivity, observed greater activity in RVLPFC during motor inhibition trials (Anderson et al., 2002; Del Ben et al., 2005; see also Rubia et al., 2005 but cf. Vollm et al., 2006…”
BackgroundWolf, D., Klasen, M., Eisner, P. D., Zepf, F. D., Zvyagintsev, M., Palomero‐Gallagher, N., Weber, R., Eisert, A., & Mathiak, K. (2018) · Brain Structure and Function · doi:10.1007/s00429-018-1693-2 · Cited by 43
“In contrast, amygdala activation was attenuated during implicit recognition of facial emotions (Del-Ben et al. 2005; Anderson et al. 2007).”
BackgroundPharmacological MRI in animal models: A useful tool for 5-HT research?
Martin, C. J., & Sibson, N. R. (2008) · Neuropharmacology · doi:10.1016/j.neuropharm.2008.08.014 · Cited by 42
“Del-Ben et al. (2005) extended this work to show that citalopram also modulated amygdala responses to neuropsychological tasks (see also Harmer et al., 2006; Arce et al., 2008).”
Robbins, T. W., & Crockett, M. J. (2010) · Handbook of behavioral neuroscience · doi:10.1016/s1569-7339(10)70093-x · Cited by 42
Effects of Modafinil on Emotional Processing in First Episode Psychosis
Scoriels, L., Barnett, J. H., Murray, G. K., Cherukuru, S., Fielding, M., Cheng, F., Lennox, B., Sahakian, B. J., & Jones, P. B. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2010.09.043 · Cited by 41
Martin, C. J. (2014) · Frontiers in Neuroscience · doi:10.3389/fnins.2014.00211 · Cited by 42
“…disease processes, and therapeutic drug effects in a wide range of human and animal models (Hariri et al., 2002; Hariri and Weinberger, 2003; Del-Ben et al., 2005, 2008; Mckie et al., 2005; Stark et al., 2006, 2008; Rao et al., 2007; Tanaka et al., 2007; Graeff and Del-Ben, 2008; Munafo et…”
BackgroundAttentional bias to emotional stimuli is altered during moderate- but not high-intensity exercise.
Tian, Q., & Smith, J. C. (2011) · Emotion · doi:10.1037/a0023568 · Cited by 43
“Among treatment paradigms, it has been shown that serotonergic treatments affect the early stages of information processing, as reflected by changes in the subcortical pathways that include decreased amygdala activation (Del-Ben et al., 2005; Murphy, Norbury, O’Sullivan, Cowen, & Harmer, 2009), whereas cognitive–behav…”
Ravinder, S., Pillai, A. G., & Chattarji, S. (2011) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2011.00088 · Cited by 44
“Furthermore, acute SSRI administration has been shown to enhance amygdala activity in healthy humans (Del-Ben et al., 2005; McKie et al., 2005).”
InfluentialGelfuso, E. A., Rosa, D. S., Fachin, A. L., Mortari, M. R., da Cunha, A. C. M. P. D. B., & Beleboni, R. O. (2013) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/18715273113129990102 · Cited by 47
“This approach permits to determine changes in specific brain areas and dose-dependent effects in both healthy patients and individuals diagnosed with social phobia and GAD after selective serotonin reuptake inhibitor (SSRI) treatment [42, 44-48].”
BackgroundGodlewska, B. R. (2018) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2018.12.010 · Cited by 42
Paroxetine-induced modulation of cortical activity supporting language representations of action
Péran, P., Démonet, J., & Cardebat, D. (2007) · Psychopharmacology · doi:10.1007/s00213-007-0939-0 · Cited by 37
“It is worth noting that a recent study on serotoninergic modulation of cognitive process substrates also revealed task-specific effects (Del-Ben et al. 2005); the authors of that study reported a drug-induced activity enhancement in the orbital frontal cortex in a task involving overt go/no-go responses, while activat…”
BackgroundResultInfluentialModulating amygdala responses to emotion: Evidence from pharmacological fMRI
Patin, A., & Hurlemann, R. (2010) · Neuropsychologia · doi:10.1016/j.neuropsychologia.2010.10.004 · Cited by 39
“Del-Ben et al. (2005) examined 12 male olunteers (mean age 24.”
InfluentialCremers, H. R., Lee, R., Keedy, S., Phan, K. L., & Coccaro, E. F. (2015) · Neuropsychopharmacology · doi:10.1038/npp.2015.187 · Cited by 37
“…on amygdala activity (Brühl et al, 2010; Henry et al, 2013) and several other single-dose and short-term citalopram administration studies found amygdala decreases (Del-Ben et al, 2005; Harmer et al, 2006; Anderson et al, 2007; Arce et al, 2008; Murphy et al, 2009; Windischberger et al, 2010).”
BackgroundKuhn, M., Weidenauer, A., & Pezawas, L. (2014) · Restorative Neurology and Neuroscience · doi:10.3233/rnn-139005 · Cited by 45
“Opposing effects have been reported for the OFC (Del-Ben et al., 2005; McCabe et al., 2010; McKie et al., 2005).”
BackgroundResultInfluentialSample Size Estimation for Comparing Parameters Using Dynamic Causal Modeling
Goulden, N., Elliott, R., Suckling, J., Williams, S. R., Deakin, J. F. W., & McKie, S. (2012) · Brain Connectivity · doi:10.1089/brain.2011.0057 · Cited by 37
“…cognitive tasks, an implicit face emotion processing task previously used by our group to investigate drug effects and the differences between psychiatric groups (Anderson et al., 2007, 2010; Del-Ben et al., 2005) and an n-back task (Honey et al., 2002; Owen et al., 2005; Schlosser et al., 2006).”
Self-citationRaab, K., Kirsch, P., & Mier, D. U. (2016) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2016.08.031 · Cited by 37
Kruschwitz, J., Walter, M., Varikuti, D. P., Jensen, J., Plichta, M. M., Haddad, L., Grimm, O., Mohnke, S., Pöhland, L., Schott, B. H., et al. (2014) · Brain Structure and Function · doi:10.1007/s00429-014-0782-0 · Cited by 44
Labuschagne, I., Croft, R. J., Phan, K., & Nathan, P. J. (2008) · Journal of Psychopharmacology · doi:10.1177/0269881108097878 · Cited by 38
Kessler, R., Schmitt, S., Sauder, T., Stein, F., Yüksel, D., Grotegerd, D., Dannlowski, U., Hahn, T., Dempfle, A., Sommer, J. B., et al. (2020) · Frontiers in Systems Neuroscience · doi:10.3389/fnsys.2020.00028 · Cited by 42
Subchronic duloxetine administration alters the extended amygdala circuitry in healthy individuals
van Marle, H. J. F., Tendolkar, I., Urner, M., Verkes, R. J., Fernández, G., & van Wingen, G. (2011) · NeuroImage · doi:10.1016/j.neuroimage.2010.12.051 · Cited by 33
The effects of acute fluoxetine administration on temporal discounting in youth with ADHD
Carlisi, C. O., Chantiluke, K. C., Norman, L. J., Christakou, A., Barrett, N., Giampietro, V., Brammer, M. J., Simmons, A., & Rubia, K. (2015) · Psychological Medicine · doi:10.1017/s0033291715002731 · Cited by 32
“2009, 2014), which are up-regulated with 5-HT agonists (Del-Ben et al. 2005).”
BackgroundInfluentialEvers, E. A. T., Sambeth, A., Ramaekers, J. G., Riedel, W. J., & van der Veen, F. M. (2010) · Current Pharmaceutical Design · doi:10.2174/138161210791293060 · Cited by 33
“This effect has been found in depressed patients who were treated for a couple of weeks [75, 76] or only pre-treated with a single dose [77].”
BackgroundResultHensler, J. G. (2010) · Handbook of behavioral neuroscience · doi:10.1016/s1569-7339(10)70090-4 · Cited by 42
Role of serotonin transporter function in rat orbitofrontal cortex in impulsive choice
Darna, M., Chow, J. J., Yates, J. R., Charnigo, R. J., Beckmann, J. S., Bardo, M. T., & Dwoskin, L. P. (2015) · Behavioural Brain Research · doi:10.1016/j.bbr.2015.07.025 · Cited by 28
“For example, systemic administration of the selective 5-HT reuptake inhibitor, citalopram, increased neuronal activity (measured by fMRI) in subregions of PFC in humans during nogo trials of a go/no-go task [59]; however, these latter BOLD signal results may be due to nonselective effects of citalopram at other monoam…”
BackgroundKotoula, V., Evans, J. W., Punturieri, C., & Zarate, C. A. (2023) · Frontiers in Neuroimaging · doi:10.3389/fnimg.2023.1110258 · Cited by 43
“2 Del-Ben et al. (2005) Aim: To determine the acute effects of citalopram on brain activation during cognitive activation tasks.”
BackgroundNK1 receptor antagonism and the neural processing of emotional information in healthy volunteers
McCabe, C., Cowen, P. J., & Harmer, C. J. (2009) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145709990150 · Cited by 27
“In fMRI studies, acute citalopram administration reduced neural responses to negative and fearful facial expressions of emotion within the amygdala (Anderson et al. 2007 ; Del-Ben et al. 2005 ; Murphy et al. 2009).”
BackgroundNandam, L. S., Hester, R., & Bellgrove, M. A. (2014) · Neuropsychologia · doi:10.1016/j.neuropsychologia.2014.01.023 · Cited by 29
“Behavioural studies have also failed to find any beneficial effect of citalopram on response inhibition (Chamberlain et al., 2006; Del-Ben et al., 2005; Langenecker et al., 2007; Macoveanu et al., 2013; Nandam et al., 2011).”
InfluentialPan, L. A., Keener, M. T., Hassel, S., & Phillips, M. L. (2009) · International Review of Psychiatry · doi:10.1080/09540260902962164 · Cited by 33
“In healthy individuals, acute and subacute administration of SSRI antidepressant medication has been associated with decreased amygdala activity to fearful facial expressions and aversive scenes (Del-Ben et al., 2005; Harmer, Mackay, Rein, Cowen, & Goodwin, 2006; Takahashi et al., 2005), while benzodiazepine dose inve…”
BackgroundFood can lift mood by affecting mood-regulating neurocircuits via a serotonergic mechanism
Kroes, M. C. W., van Wingen, G. A., Wittwer, J., Mohajeri, M. H., Kloek, J., & Fernández, G. (2013) · NeuroImage · doi:10.1016/j.neuroimage.2013.09.041 · Cited by 38
“Previous work has yielded positive, yet mixed, results of serotonergic effects on neural responses during emotional processing (Bigos et al., 2008; Del-Ben et al., 2005; Di Simplicio et al., 2013).”
ResultInteraction of emotion and cognitive control along the psychosis continuum: A critical review
Duggirala, S. X., Schwartze, M., Pinheiro, A. P., & Kotz, S. A. (2019) · International Journal of Psychophysiology · doi:10.1016/j.ijpsycho.2019.11.004 · Cited by 30
Drueke, B., Boecker, M., Schlaegel, S., Moeller, O., Hiemke, C., Gründer, G., & Gauggel, S. (2010) · Human Psychopharmacology: Clinical and Experimental · doi:10.1002/hup.1141 · Cited by 26
“Neuroimaging studies found enhanced responses of lateral orbitofrontal cortex (BA 47) to the no-go condition after administration of the selective 5-HT reuptake inhibitor (SSRI) citalopram (Del-Ben et al., 2005).”
BackgroundLöchner, C., Simmons, C., Kidd, M., Chamberlain, S. R., Fineberg, N. A., van Honk, J., Ipser, J., & Stein, D. J. (2011) · Behavioural Brain Research · doi:10.1016/j.bbr.2011.09.029 · Cited by 25
Ilieva, I. P. (2014) · Neuroethics · doi:10.1007/s12152-014-9226-z · Cited by 25
Serotonergic modulation of face-emotion recognition
Del‐Ben, C. M., Ferreira, C. A., Alves-Neto, W. C., & Graeff, F. G. (2008) · Brazilian Journal of Medical and Biological Research · doi:10.1590/s0100-879x2008000400002 · Cited by 27
“Of these, ten (15-24) evaluated the effects of acute manipulation of the 5-HT system.”
BackgroundResultSelf-citationAllelic variation in 5-HTTLPR and the effects of citalopram on the emotional neural network
Ma, Y., Li, B., Wang, C., Zhang, W., Rao, Y., & Han, S. (2015) · British Journal of Psychiatry · doi:10.1192/bjp.bp.114.150128 · Cited by 23
The role of 5-HT in response inhibition and re-engagement
Drueke, B., Schlaegel, S. M. A., Seifert, A., Moeller, O., Gründer, G., Gauggel, S., & Boecker, M. (2013) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2013.05.005 · Cited by 23
“…on task performance is in line with various studies that found no effect of 5-HT modulation on response inhibition using either a stop signal task (Bari et al., 2009; Clark et al., 2005; Chamberlain et al., 2006) or a go/no-go task (Del-Ben et al., 2005; Evers et al., 2006, Rubia et al., 2005).”
BackgroundResultInfluentialLee, T., Liu, H., Wai, Y., Ko, H.-J., & Lee, S. (2012) · Psychiatry Research Neuroimaging · doi:10.1016/j.pscychresns.2012.04.010 · Cited by 25
“However, the amygdala has been noticed to be modulated pharmacologically in emotional processing as opposed to purely cognitive tasks (Anderson et al., 2008; Del-Ben et al., 2005).”
Decreased Cingulate Cortex activation during cognitive control processing in bipolar disorder
Gruber, S. A., Dahlgren, M. K., Sagar, K. A., Gönenç, A., Norris, L. A., Cohen, B. M., Öngür, D., & Lewandowski, K. E. (2017) · Journal of Affective Disorders · doi:10.1016/j.jad.2017.02.003 · Cited by 23
Young, K. D., Friedman, E. S., Collier, A. B., Berman, S., Feldmiller, J., Haggerty, A. E., Thase, M. E., & Siegle, G. J. (2020) · NeuroImage Clinical · doi:10.1016/j.nicl.2020.102388 · Cited by 28
“However, the majority of reactivity studies found significant changes to negative stimuli only and either did not assess (Anand et al., 2007; Anderson et al., 2007; Del-Ben et al., 2005; Fu et al., 2004; Phillips et al., 2015) or did not find changes (Arce et al.”
BackgroundGrimm, S., Keicher, C., Paret, C., Niedtfeld, I., Beckmann, C. F., Mennes, M., Just, S., Sharma, V., Fuertig, R., Herich, L., et al. (2022) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2022.10.009 · Cited by 23
Using MRI to measure drug action: caveats and new directions
Murphy, S. E., & Mackay, C. E. (2010) · Journal of Psychopharmacology · doi:10.1177/0269881110372547 · Cited by 23
“…the interpretability of phMRI studies is to only consider differences in activation patterns between drug and placebo groups within a taskspecific context, by restricting the analysis of drug effects to those regions within which there is amain effect of the task (e.g. Del-Ben et al., 2005).”
BackgroundOuthred, T., Das, P., Dobson‐Stone, C., Felmingham, K. L., Bryant, R. A., Nathan, P. J., Malhi, G. S., & Kemp, A. H. (2016) · Journal of Affective Disorders · doi:10.1016/j.jad.2016.02.019 · Cited by 22
“5-HTT is encoded by the gene SLC6A4, the expression of which is modulated by a polymorphism in the promoter region, termed 5-HTTLPR (Del-Ben et al., 2005; Heils et al., 1996; Lesch et al., 1996).”
BackgroundRivera-Bonet, C. N., Hwang, G., Hermann, B. P., Struck, A. F., Cook, C. J., Nair, V. A., Mathis, J. R., Allen, L., Almane, D. N., Arkush, K., et al. (2020) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2020.107172 · Cited by 23
“Right BA47 has been associated with affective prosody [71,72], perception of angry facial expressions [73] and behavioral inhibition [74,75] from many fMRI task activation studies.”
BackgroundAltered affective processing in bipolar disorder: An fMRI study
Sagar, K. A., Dahlgren, M. K., Gönenç, A., & Gruber, S. A. (2013) · Journal of Affective Disorders · doi:10.1016/j.jad.2013.05.019 · Cited by 24
“…and selective serotonin reuptake inhibitors (SSRIs) have generally been shown to attenuate activation (Arce et al., 2008; Bell et al., 2005; Del-Ben et al., 2005; Murphy et al., 2009; Paulus et al., 2005), and in this study, BPD participants overall showed increased activation (number of…”
Ruhé, H. G., Koster, M., Booij, J., van Herk, M., Veltman, D. J., & Schene, A. H. (2014) · Psychiatry Research: Neuroimaging · doi:10.1016/j.pscychresns.2013.12.003 · Cited by 20
Saunders, K., Goodwin, G. M., & Rogers, R. D. (2015) · Journal of Personality Disorders · doi:10.1521/pedi_2015_29_216 · Cited by 22
Neuroanatomy of Anxiety: A Brief Review
Schmidt, C. K., Khalid, S., Loukas, M., & Tubbs, R. S. (2018) · Cureus · doi:10.7759/cureus.2055 · Cited by 25
“Citalopram, an SSRI, has been shown to influence neural changes in anxiety disorder patients [36], driving the attenuation of the lateral OFC and right amygdala to aversive faces [37].”
BackgroundWong, N. M. L., Dipasquale, O., Turkheimer, F., Findon, J. L., Wichers, R., Dimitrov, M., Murphy, C. M., Stoencheva, V., Robertson, D., Murphy, D., et al. (2022) · Journal of Psychopharmacology · doi:10.1177/02698811221092509 · Cited by 20
Klomp, A., van Wingen, G. A., de Ruiter, M. B., Caan, M. W. A., Denys, D. A. J. P., & Reneman, L. (2013) · NeuroImage · doi:10.1016/j.neuroimage.2013.03.002 · Cited by 20
“…with Murphy et al. (2009) and Takahashi et al. (2005) and with findings after an intravenous or chronic SSRI challenge (Anderson et al., 2007, 2011; Del-Ben et al., 2005; Harmer et al., 2006; Windischberger et al., 2010), we expect this effect to be a decrease, although increased amygdala…”
BackgroundInfluentialCardoso de Almeida, Jr., Phillips, M., Cerqueira, C., Zilberman, M., Lobo, D., Henna, E., Tavares, H., Amaro, E., Gorenstein, C., Gentil, V., et al. (2010) · Journal of Psychopharmacology · doi:10.1177/0269881109105786 · Cited by 18
Ma, Y., Wang, Z., He, J., Sun, J., Guo, C., Du, Z., Chen, L., Luo, Y., Gao, D., Yang, H., et al. (2022) · Frontiers in Neurology · doi:10.3389/fneur.2022.931838 · Cited by 21
Direct serotonin release in humans shapes aversive learning and inhibition
Colwell, M., Tagomori, H., Shang, F., Cheng, H. I., Wigg, C., Browning, M. D., Cowen, P. J., Murphy, S. E., & Harmer, C. J. (2024) · Nature Communications · doi:10.1038/s41467-024-50394-x · Cited by 27
“In humans, SSRI challenge results in improvement or no change in action cancellation ability (stop signal) 16,88 , while action restraint ability (go/no-go) remains unchanged or impaired 17 – 19 ,89 .”
BackgroundHornbøll, B., Macoveanu, J., Nejad, A. B., Rowe, J. B., Elliott, R., Knudsen, G. M., Siebner, H. R., & Paulson, O. B. (2018) · Scientific Reports · doi:10.1038/s41598-018-36350-y · Cited by 16
Self-citationMarutani, T., Yahata, N., Ikeda, Y., Ito, T., Yamamoto, M., Matsuura, M., Matsushima, E., Okubo, Y., Suzuki, H., & Matsuda, T. (2011) · Psychiatry and Clinical Neurosciences · doi:10.1111/j.1440-1819.2011.02189.x · Cited by 16
“The MNI coordinates [x y z] of ROI were left GP [-24 -10 0], right GP [20 -10 0], left insula [-38 -14 10], right insula [40 2 8], left putamen [-22 8 -2], right putamen [28 4 8], right NAcc [10 10 -14], left caudate [-6 12 4], left DLPFC [-36 32 26] and left primary motor cortex [-32 -22 54].”
Resting functional connectivity in social anxiety disorder and the effect of pharmacotherapy
Doruyter, A., Lochner, C., Jordaan, G. P., Stein, D. J., Dupont, P., & Warwick, J. M. (2016) · Psychiatry Research Neuroimaging · doi:10.1016/j.pscychresns.2016.04.009 · Cited by 16
Early effects of duloxetine on emotion recognition in healthy volunteers
Bamford, S., Penton-Voak, I., Pinkney, V., Baldwin, D. S., Munafò, M. R., & Garner, M. (2015) · Journal of Psychopharmacology · doi:10.1177/0269881115570085 · Cited by 15
“, 2003), and modulate amygdala responses to emotional faces (Anderson et al., 2007; Del-Ben et al., 2005; Murphy et al., 2009).”
Outhred, T., Das, P., Dobson‐Stone, C., Felmingham, K. L., Bryant, R. A., Nathan, P. J., Malhi, G. S., & Kemp, A. H. (2014) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/0004867414533837 · Cited by 19
“In terms of single-dose SSRI administration effects, the decreases in amygdala reactivity to negative emotional stimuli (Anderson et al., 2007; Del-Ben et al., 2005; Heils et al., 1996; Lesch et al., 1996; Murphy et al., 2009) and increases in amygdala to positive emotional stimuli (Outhred et al.,…”
BackgroundInfluentialVarga, Z. K., Pejtsik, D., Bíró, L., Zsigmond, Á., Varga, M., Tóth, B., Salamon, V., Annus, T., Mikics, É., & Aliczki, M. (2020) · Journal of Neuroscience · doi:10.1523/jneurosci.2178-19.2020 · Cited by 17
“…that 5-HT downregulates responsivity partially through its actions on amygdala function (which theory is supported by several human fMRI studies investigating the mechanisms of selective 5-HT reuptake inhibitors in aversive contexts) (Del-Ben et al., 2005; Harmer et al., 2006; Murphy et al., 2009).”
BackgroundA single dose of mirtazapine attenuates neural responses to self-referential processing
Komulainen, E., Heikkilä, R., Meskanen, K., Raij, T. T., Nummenmaa, L., Lahti, J. M. T., Jylhä, P. J., Melartin, T. K., Harmer, C. J., Isometsä, E. T., et al. (2015) · Journal of Psychopharmacology · doi:10.1177/0269881115616384 · Cited by 21
“In healthy volunteers, amygdala responses to negative visual stimuli seem to decrease as fast as a few hours or days after administration of several different antidepressants (Anderson et al., 2007; Del-Ben et al., 2005; Murphy et al., 2009; Norbury et al., 2007; Takahashi et al., 2005), even though increased amygdala…”
BackgroundShi, H., Wang, X., & Yao, S. (2013) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2013.00459 · Cited by 18
Rational approaches to the neurobiologic study of youth at risk for bipolar disorder and suicide
Sublette, M. E., Oquendo, M. A., & Mann, J. J. (2006) · Bipolar Disorders · doi:10.1111/j.1399-5618.2006.00372.x · Cited by 18
Neural Correlates of Anhedonia as a Trait Marker for Depression
McCabe, C. (2014) · Springer eBooks · doi:10.1007/978-94-017-8610-2_6 · Cited by 15
“Early investigations into the effects of current pharmacological treatments on the neural response to differing emotional tasks found that antidepressants [ 76 – 78 ] mostly attenuate the neural response to fearful or aversive stimuli which is thought to underpin the”
BackgroundWang, L., Li, X., Li, K., Su, Y., Zeng, Y., Zhang, Q., Wang, G., Jin, Z. H., Kong, Q., & Si, T. (2016) · Metabolic Brain Disease · doi:10.1007/s11011-016-9871-5 · Cited by 15
Atomoxetine and citalopram alter brain network organization in Parkinson’s disease
Borchert, R. J., Rittman, T., Rae, C. L., Passamonti, L., Jones, S. P., Vatansever, D., Vázquez Rodríguez, P., Ye, Z., Nombela, C., Hughes, L. E., et al. (2019) · Brain Communications · doi:10.1093/braincomms/fcz013 · Cited by 14
“For example, the behavioural effects of serotonergic manipulations on response inhibition are mediated by the prefrontal cortex (Del-Ben et al., 2005; Macoveanu et al., 2013).”
BackgroundPasquereau, B., Drui, G., Saga, Y., Richard, A., Millot, M., Météreau, É., Sgambato, V., Tobler, P. N., & Tremblay, L. (2021) · Neuropsychopharmacology · doi:10.1038/s41386-021-00991-x · Cited by 18
Imaging genetics: implications for research on variable antidepressant drug response
Rabl, U., Scharinger, C., Müller, M., & Pezawas, L. (2010) · Expert Review of Clinical Pharmacology · doi:10.1586/ecp.10.35 · Cited by 17
Greenfield, M. S., Wang, Y., & Msghina, M. (2023) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.988893 · Cited by 15
“Although fNIRS does not allow examination of deeper brain areas, studies using fMRI looking at the acute effects of SSRIs have shown attenuated amygdala activity (42, 43, 46), an area with rich sensory input implicated in emotion perception and in coordinating responses to threatening stimuli together with PFC (94).”
BackgroundBoucherie, D. E., Reneman, L., Booij, J., Martins, D., Dipasquale, O., & Schrantee, A. (2023) · Journal of Psychopharmacology · doi:10.1177/02698811231211154 · Cited by 14
“…paradigms have frequently reported altered activation in (networks encompassing) the limbic system in response to SSRIs (Arce et al., 2008; Del-Ben et al., 2005; Grady et al., 2013; Selvaraj et al., 2018; Windischberger et al., 2010), which has been implicated in aberrant emotion…”
BackgroundResultInfluentialVariation of 5-HTTLPR and deficits in emotion regulation: A pathway to risk?
Gilman, T. L., Latsko, M. S., Matt, L. M., Flynn, J. J., Cabrera, O. D. L. C., Douglas, D. G., Jasnow, A. M., & Coifman, K. G. (2015) · Psychology & Neuroscience · doi:10.1037/pne0000017 · Cited by 19
“Additional support for the emotional influences of 5-HTT function comes from pharmacological studies exploring the neuroemotional impacts of 5-HTT-inhibiting drugs in humans (Del-Ben et al., 2005; Ma, 2015; Ma et al., 2015; Murphy, Norbury, O’Sullivan, Cowen, & Harmer, 2009).”
BackgroundHautzel, H., Müller, H., Herzog, H. R., & Grandt, R. (2011) · NeuroImage · doi:10.1016/j.neuroimage.2011.06.009 · Cited by 13
Citalopram Neuroendocrine Challenge Shows Altered Tryptophan and Kynurenine Metabolism in Migraine
Gecse, K., Édes, A. E., Nagy, T., Demeter, A. K., Virág, D., Király, M., Kiss, B. D., Ludányi, K., Környei, Z., Dénes, Á., et al. (2022) · Cells · doi:10.3390/cells11142258 · Cited by 14
Mood and personality effects in healthy participants after chronic administration of sertraline
Simmons, J. G., & Allen, N. B. (2011) · Journal of Affective Disorders · doi:10.1016/j.jad.2011.06.007 · Cited by 13
“…of an SSRI have generally not been found to influence self-reported mood in healthy adults (e.g., Bhagwagar et al., 2004; Browning et al., 2007; Del-Ben et al., 2005; Grillon et al., 2007; Harmer et al., 2003), although some studies have found evidence of increased levels of anxiety (e.g.,…”
BackgroundKomulainen, E., Glerean, E., Meskanen, K., Heikkilä, R., Nummenmaa, L., Raij, T. T., Lahti, J. M. T., Jylhä, P. J., Melartin, T. K., Isometsä, E. T., et al. (2017) · Psychiatry Research Neuroimaging · doi:10.1016/j.pscychresns.2017.03.009 · Cited by 13
“At the neural level, antidepressants decrease amygdala responses to negative stimuli (Anderson et al., 2007; Del-Ben et al., 2005; Murphy et al., 2009; Takahashi et al., 2005), even though increased responses (Bigos et al.”
BackgroundInfluentialHinkelmann, K., Dragoi, L., Gompf, J., Muhtz, C., Demiralay, C., Yassouridis, A., Wiedemann, K., & Kellner, M. B. (2010) · Psychiatry Research · doi:10.1016/j.psychres.2010.03.008 · Cited by 13
“Several fMRI studies found attenuated responses to aversive stimuli especially in the amygdala region after single-dose (Del-Ben et al., 2005; Anderson et al., 2007; Bigos et al., 2008; Murphy et al., 2009) and chronic SSRI administration (Arce et al.”
BackgroundHansen, H. D., Lindberg, U., Ozenne, B., Fisher, P. M., Johansen, A., Svarer, C., Keller, S. H., Hansen, A. E., & Knudsen, G. M. (2020) · Human Brain Mapping · doi:10.1002/hbm.25156 · Cited by 10
Lewis, C. A., Mueller, K., Zsido, R. G., Reinelt, J. D., Regenthal, R., Okon‐Singer, H., Forbes, E. E., Villringer, A., & Sacher, J. (2021) · Journal of Psychiatry and Neuroscience · doi:10.1503/jpn.200121 · Cited by 11
Metadata
- Authors
- Del-Ben, C. M., Deakin, J. F. W., Mckie, S., Delvai, N. A., Williams, S. R., Elliott, R., Dolan, M., & Anderson, I. M.
- Affiliations
- University of Manchester (GB)
- Corresponding author
- Anderson, Ian M
- Venue
- Neuropsychopharmacology
- Published
- 2005-04-13
- Volume
- 30
- Issue
- 9
- Pages
- 1724-1734
- ISSN
- 0893-133X (ISSN-L)
- 1740-634X
- OpenAlex
- W2104461993
- Cited by
- 260
- References
- 88
- Citations by year
- 2026: 1 · 2025: 4 · 2024: 4 · 2023: 4 · 2022: 6 · 2021: 10 · 2020: 12 · 2019: 7 · 2018: 7 · 2017: 8 · 2016: 9 · 2015: 18 · 2014: 22 · 2013: 21 · 2012: 16
- FWCI
- 5.93
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Neuropsychopharmacology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Fundação de Amparo à Pesquisa do Estado de São Paulo
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
- Medical Research Council
- Topics
- Life Sciences › Neuroscience › Cognitive Neuroscience › Neural and Behavioral Psychology Studies
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Keywords
- citalopram, serotonin, go/no-go task, loss aversion, emotion recognition, orbitofrontal cortex, amygdala, impulsivity, drug challenge
- MeSH terms
- Adult, Brain Mapping, Cerebral Cortex, Decision Making, Humans, Image Processing, Computer-Assisted, Functional Laterality, Magnetic Resonance Imaging, Male, Neuropsychological Tests, Oxygen, Pattern Recognition, Visual, Citalopram, Single-Blind Method, Cross-Over Studies, Antidepressive Agents, Second-Generation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.